U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07327307) titled 'Real World Evidence Study of SYN023 in Children Exposed to Rabies' on Dec. 24, 2025.
Brief Summary: This observational study is an open-label, prospective, multi-center design. The goal is to evaluate the long-term clinical survival outcomes at 3 months and 1 year in individuals under 18 years of age with WHO Category III rabies exposure who have received real-world Post-Exposure Prophylaxis (PEP) with Zamerovimab and Mazorelvimab Injection / other passive immunization products combined with the rabies vaccine.
Participants will: (1) Have their clinical protection outcomes (rabies-free survival status) registered and evaluated on Da...